![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 02, 2020 12:52:52 PM
Product works amazingly well, not up for debate, irrefutable.
Nonsense like former CEO reading that average FDA clearance/approval, whatever, costs $30 million, so he screams loud and long that BIEL spent $30 million. Total lies. BIEL spent, maybe $1 to $2 million, tops. Whelans and lawyers got the rest.
Efficacy of ActiPatch is positive in >70% of cases. Also irrefutable. It is a brilliant, patented, drug-free, side-effect free, pain management device for the masses. Share price has been in the toilet because of former CEO management styles, of people and the business.
Still deep in the toilet because of (i)the toxicity of his name still involved, (ii)no CE Mark, (iii)no deals and (iv)the outrageous share structure. Solutions provided, no need to repeat them. Not complicated.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM